ArticlePloS one2026

Retraction: Application of in-silico drug discovery techniques to discover a novel hit for target-specific inhibition of SARS-CoV-2 Mpro's revealed allosteric binding with MAO-B receptor: A theoretical study to find a cure for post-covid neurological disorder.

PLOS One EditorsPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.